Impetigo (DBCOND0000235)

Identifiers

Synonyms

Impetigo, unspecified / Impetigo (disorder) / Impetigo NOS / Impetigo Contagiosa

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Cefuroxime	A cephalosporin indicated for the treatment of a variety of infections including acute bacterial otitis media, several upper respiratory tract infections, skin infections, urinary tract infections, gonorrhea, early Lyme disease, and impetigo.	Penicillin-binding protein 1Atarget Solute carrier family 15 member 1transporter Solute carrier family 15 member 2transporter
Human vaccinia virus immune globulin	A purified gamma globulin used to treat vaccinia infections where skin is compromised, or infections of the eyes, mouth, or other areas where vaccinia infections present a special hazard.	No drug targets
Mupirocin	An antibacterial ointment used to treat impetigo and secondary skin infections caused by Staphylococcus aureus and Streptococcus pyogenes.	Isoleucine--tRNA ligasetarget
Neomycin	An aminoglycoside antibiotic agent used orally and topically to treat a wide variety of infections in the body.	30S ribosomal protein S12target 16S ribosomal RNAtarget Extracellular calcium-sensing receptortarget
Ozenoxacin	A quinolone antibiotic used to treat impetigo caused by susceptible bacteria.	DNA gyrase subunit Atarget DNA topoisomerase 4 subunit Atarget DNA gyrase subunit Atarget DNA gyrase subunit Btarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04287777	Safety and Efficacy of Mupirocin Gel in Children With Impetigo	Mupirocin	treatment	3	completed
NCT00884728	Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory	No drug interventions	Not Available	Not Available	completed
NCT03177993	Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji	Ivermectin	treatment	Not Available	completed
NCT02902822	Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo	No drug interventions	diagnostic	Not Available	completed
NCT00758862	The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo	No drug interventions	treatment	2	completed
NCT03429595	Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo	No drug interventions	treatment	2	completed
NCT00626795	Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)	Mupirocin	treatment	2	completed
NCT01367314	Safety and Efficacy of Topical NVC-422 Gel in Impetigo	Auriclosene	treatment	2	completed
NCT02090764	Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo	Ozenoxacin	treatment	3	completed
NCT01397461	Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo	Ozenoxacin Retapamulin	treatment	3	completed
NCT01153828	EU PV for Retapamulin-Prescribing	Fusidic acid Mupirocin Retapamulin	Not Available	Not Available	completed
NCT01611909	Citriodiol® and Impetigo	No drug interventions	treatment	2 / 3	unknown_status
NCT00986856	Fucidin® Cream in the Treatment of Impetigo	Fusidic acid	treatment	4	terminated
NCT01670032	Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo	No drug interventions	treatment	2 / 3	completed
NCT01943136	The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial	Mupirocin	treatment	1	unknown_status
NCT02775617	Azithromycin - Ivermectin Mass Drug Administration for Skin Disease	Azithromycin Ivermectin Permethrin	treatment	4	completed
NCT00133848	Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment	Retapamulin	treatment	3	completed
NCT01171326	Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients	Minocycline	treatment	2	completed
NCT05226260	Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care	No drug interventions	other	Not Available	active_not_recruiting
NCT01126268	Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection	Retapamulin	treatment	4	completed